OncoVista Innovative Therapies Inc (OVIT)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
OncoVista Innovative Therapies Total Liabilities (Quarterly): 6.651M for Sept. 30, 2015
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2015 | 6.651M |
June 30, 2015 | 7.065M |
March 31, 2015 | 5.997M |
December 31, 2014 | 5.676M |
September 30, 2014 | 4.211M |
June 30, 2014 | 4.419M |
March 31, 2014 | 3.507M |
December 31, 2013 | 3.216M |
September 30, 2013 | 2.907M |
June 30, 2013 | 2.586M |
March 31, 2013 | 2.437M |
December 31, 2012 | 2.254M |
September 30, 2012 | 2.231M |
June 30, 2012 | 2.303M |
March 31, 2012 | 2.517M |
December 31, 2011 | 2.313M |
September 30, 2011 | 2.214M |
June 30, 2011 | 2.261M |
March 31, 2011 | 2.232M |
December 31, 2010 | 1.894M |
September 30, 2010 | 11.83M |
June 30, 2010 | 10.54M |
Date | Value |
---|---|
March 31, 2010 | 10.97M |
December 31, 2009 | 11.66M |
September 30, 2009 | 11.39M |
June 30, 2009 | 10.43M |
March 31, 2009 | 9.470M |
December 31, 2008 | 8.900M |
September 30, 2008 | 8.629M |
June 30, 2008 | 9.291M |
March 31, 2008 | 9.958M |
December 31, 2007 | 8.942M |
September 30, 2007 | 0.00 |
June 30, 2007 | 1.973M |
March 31, 2007 | 1.886M |
December 31, 2006 | 7.935M |
September 30, 2006 | 1.795M |
June 30, 2006 | 1.780M |
March 31, 2006 | 1.811M |
December 31, 2005 | 1.652M |
September 30, 2005 | 1.636M |
June 30, 2005 | 1.561M |
March 31, 2005 | 1.479M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
FluoroPharma Medical Inc | 10.51M |
RenovaCare Inc | 2.515M |
Xeno Transplants Corp | -- |
Entia Biosciences Inc | 2.406M |
Regenerx Biopharmaceuticals Inc | 3.931M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.0613M |
Shareholders Equity (Quarterly) | -6.590M |